ArticleCardiology journal2020

To drop or not to drop the antiplatelet agent, that is the question for patients with atrial fibrillation and chronic coronary syndrome undergoing percutaneous coronary intervention.

Yongcheol Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.